Economic evaluation of AbobotulinumtoxinA vs OnabotulinumtoxinA in real-life clinical management of cervical dystonia

Overview of attention for article published in Journal of Clinical Movement Disorders, February 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 tweeters

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 8 Mendeley

Summary Twitter Dimensions citations

So far, Altmetric has seen 4 tweets from 3 users, with an upper bound of 2,697 followers.

RT @AusDystoniaSG: Economic evaluation of AbobotulinumtoxinA vs OnabotulinumtoxinA in real-life clinical management of cervical #dystonia -…

28 Feb 2020

Reply Retweet Favourite

Economic evaluation of AbobotulinumtoxinA vs OnabotulinumtoxinA in real-life clinical management of cervical #dystonia - treatment with aboBoNT-A may be less costly & lead to improved clinical outcomes when compared with onaBoNT-A. Click link to read m

28 Feb 2020

Reply Retweet Favourite

RT @NeuroPsychBMC: Economic evaluation of AbobotulinumtoxinA vs OnabotulinumtoxinA in real-life clinical management of cervical dystonia h…

13 Feb 2020

Reply Retweet Favourite

Economic evaluation of AbobotulinumtoxinA vs OnabotulinumtoxinA in real-life clinical management of cervical dystonia https://t.co/99UdccbAiH

13 Feb 2020

Reply Retweet Favourite

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity.